TXMD - TherapeuticsMD jumps 12% as top investor discloses insider purchase

• The shares of the women’s healthcare company TherapeuticsMD ( NASDAQ: TXMD ) surged ~12% on Tuesday after one of its leading institutional holders Rubric Capital Management announced the purchase of approximately 82.6K of company shares.
• The hedge fund which had over 10% of company ownership has bought the shares on Friday and Monday at $5.56 and $6.03 apiece. The transactions valued at $467.4K has increased its holding by ~4%.
• The Tuesday’s disclosure on the insider transaction comes days after TherapeuticsMD ( TXMD ) terminated its merger agreement with Athene Merger, an affiliate of the private equity firm EW Healthcare Partners.
• The deal fell apart after Athene failed to acquire the required number of TXMD shares during tender offer which the private equity firm previously extended noting that TherapeuticsMD ( TXMD ) risked bankruptcy without the closure of the deal.

For further details see: